Concentrix Corp·4

Mar 27, 8:42 AM ET

VEZINA ANN F 4

4 · Concentrix Corp · Filed Mar 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Concentrix (CNXC) Director Ann F. Vezina Receives 7,701 RSUs

What Happened

  • Ann F. Vezina, a director of Concentrix Corp (CNXC), received an award of 7,701 restricted stock units (RSUs) on 2026-03-25. The units were granted at $0.00 per share (an equity award rather than a market purchase), so no cash changed hands in this transaction.
  • This is a compensation/award transaction (code A) rather than a purchase or sale, and therefore does not by itself indicate buying or selling sentiment.

Key Details

  • Transaction date: 2026-03-25; Filing date (Form 4): 2026-03-27.
  • Price: $0.00 per share; Total reported cash value on Form 4: $0.
  • Shares acquired: 7,701 restricted stock units (RSUs).
  • Shares owned after transaction: Not specified in the provided Form 4 excerpt.
  • Footnote: F1 — These RSUs vest in full on the earlier of (x) the one‑year anniversary of the grant date or (y) the date of Concentrix's 2027 Annual Meeting of Stockholders.
  • No 10b5‑1 plan, tax‑withholding disposition, or late filing flag was indicated in the provided data.

Context

  • RSUs are a form of deferred equity compensation: they convert into shares (or cash equivalent) only when they vest. Recipients typically cannot sell vested shares until they actually receive them and any required tax withholding is addressed.
  • Awards to directors are common and are typically part of standard compensation programs; they are routine and not the same signal as an open‑market purchase by an insider.

Insider Transaction Report

Form 4
Period: 2026-03-25
VEZINA ANN F
Director
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-25+7,70119,648 total
Footnotes (1)
  • [F1]Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.
Signature
/s/ Andrew Farwig, Attorney-in-Fact|2026-03-27

Documents

1 file
  • 4
    wk-form4_1774615375.xmlPrimary

    FORM 4